Risk factors associated with NAFLD recurrence include: (a) post-transplant weight gain, (b) steroid use, (c) presence of MetS, and (d) PNPLA3 rs738409 in the recipient [50,52,53,54]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.